124 related articles for article (PubMed ID: 2632113)
1. [Erythrocyte aggregation and retinal vein occlusion. Preliminary data for a randomized study on the efficacy of anti-erythrocyte aggregation (troxerutin) in retinal vein occlusion].
Glacet-Bernard A; Coscas G; Lelong F; Chabanel A; Samama M; Taccoen A
Bull Soc Ophtalmol Fr; 1989 Dec; 89(12):1393-6. PubMed ID: 2632113
[TBL] [Abstract][Full Text] [Related]
2. [Increase of erythrocyte aggregation in retinal vein occlusion].
Glacet-Bernard A; Chabanel A; Coscas G; Lelong F; Samama M
J Fr Ophtalmol; 1990; 13(10):500-5. PubMed ID: 2081840
[TBL] [Abstract][Full Text] [Related]
3. Role of haemorheological factors in patients with retinal vein occlusion.
Sofi F; Mannini L; Marcucci R; Bolli P; Sodi A; Giambene B; Menchini U; Gensini GF; Abbate R; Prisco D
Thromb Haemost; 2007 Dec; 98(6):1215-9. PubMed ID: 18064316
[TBL] [Abstract][Full Text] [Related]
4. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.
Lip PL; Blann AD; Jones AF; Lip GY
Eye (Lond); 1998; 12 ( Pt 2)():245-51. PubMed ID: 9683948
[TBL] [Abstract][Full Text] [Related]
5. Branch retinal vein occlusion: the pathogenetic role of blood viscosity.
Piermarocchi S; Segato T; Bertoja H; Midena E; Zucchetto M; Girolami A; Procidano M; Mares M
Ann Ophthalmol; 1990 Aug; 22(8):303-11. PubMed ID: 2221710
[TBL] [Abstract][Full Text] [Related]
6. [Factor VIII/Ag (von Willebrand) and protein C. Erythrocyte deformability and aggregability. The risk parameters of retinal vein occlusion].
Cortinovis A; Crippa A; Crippa M
Minerva Med; 1994 May; 85(5):211-9. PubMed ID: 8028749
[TBL] [Abstract][Full Text] [Related]
7. Increased red blood cell aggregation in retinal vein occlusion.
Chabanel A; Glacet-Bernard A; Lelong F; Taccoen A; Coscas G; Samama MM
Br J Haematol; 1990 May; 75(1):127-31. PubMed ID: 2375911
[TBL] [Abstract][Full Text] [Related]
8. [Retinal vein occlusion and hyperhomocysteinemia].
Blondel J; Glacet-Bernard A; Bayani N; Blacher J; Lelong F; Nordmann JP; Coscas G; Soubrane G
J Fr Ophtalmol; 2003 Mar; 26(3):249-53. PubMed ID: 12746600
[TBL] [Abstract][Full Text] [Related]
9. Elevated erythrocyte aggregation in patients with central retinal vein occlusion and without conventional risk factors.
Glacet-Bernard A; Chabanel A; Lelong F; Samama MM; Coscas G
Ophthalmology; 1994 Sep; 101(9):1483-7. PubMed ID: 8090451
[TBL] [Abstract][Full Text] [Related]
10. Plasma homocysteine and cysteine levels in retinal vein occlusion.
Pinna A; Carru C; Zinellu A; Dore S; Deiana L; Carta F
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4067-71. PubMed ID: 16936125
[TBL] [Abstract][Full Text] [Related]
11. [Bilateral central retinal vein occlusion and circulating anticoagulant].
Lureau MA; Glacet-Bernard A; Coscas G
J Fr Ophtalmol; 1995; 18(6-7):468-72. PubMed ID: 7560789
[TBL] [Abstract][Full Text] [Related]
12. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
[TBL] [Abstract][Full Text] [Related]
13. Activated protein C resistance is a risk factor for central retinal vein occlusion.
Marcucci R; Bertini L; Liotta AA; Rogolino A; Antonucci E; Ilari I; Pepe G; Prisco D
Ann Ital Med Int; 2000; 15(3):195-8. PubMed ID: 11059059
[TBL] [Abstract][Full Text] [Related]
14. [Risk factors and visual prognosis of 407 patients with retinal vein occlusion].
Zhang HR; Xia YJ
Zhonghua Yan Ke Za Zhi; 1991 Sep; 27(5):271-4. PubMed ID: 1815918
[TBL] [Abstract][Full Text] [Related]
15. Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion.
Pinna A; Carru C; Solinas G; Zinellu A; Carta F
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2747-52. PubMed ID: 17525208
[TBL] [Abstract][Full Text] [Related]
16. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.
Dodson PM; Haynes J; Starczynski J; Farmer J; Shigdar S; Fegan G; Johnson RJ; Fegan C
Eye (Lond); 2003 Aug; 17(6):772-7. PubMed ID: 12928694
[TBL] [Abstract][Full Text] [Related]
17. Haemorheological changes in patients with retinal vein occlusion after isovolaemic haemodilution.
Wiek J; Schade M; Wiederholt M; Arntz HR; Hansen LL
Br J Ophthalmol; 1990 Nov; 74(11):665-9. PubMed ID: 2223704
[TBL] [Abstract][Full Text] [Related]
18. Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction.
Vayá A; Falcó C; Réganon E; Vila V; Martínez-Sales V; Corella D; Contreras MT; Aznar J
Thromb Haemost; 2004 Feb; 91(2):354-9. PubMed ID: 14961164
[TBL] [Abstract][Full Text] [Related]
19. [Hemorheological changes in retinal vein occlusions].
Peduzzi M; Debbia A; Guerrieri F; Zirilli E; Bolzani R; Barbieri U
Ric Clin Lab; 1985; 15 Suppl 1():321-6. PubMed ID: 4035223
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of visual prognosis and correlative factors in retinal vein occlusion].
Zhang H; Xia Y
Zhonghua Yan Ke Za Zhi; 2002 Feb; 38(2):98-102. PubMed ID: 11955310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
